Cancer Patient Care Program

This grant opportunity seeks to ensure that all Australian’s living with cancer have access to high-quality and culturally safe support throughout their cancer experience. Acknowledging the existing national cancer screening programs and funding provided for more commonly diagnosed cancers, this grant opportunity will prioritise activities that focus on increasing equity across tumour types and/or priority populations. 

The Cancer Patient Support Program (the Program) will support, one-off, time-limited activities that provide national leadership on emerging priorities across the cancer control continuum. 

Assessment and notification of outcomes will be divided into three Submission Periods during the life of this Program. Each Submission Period will include assessment of applications that have been submitted to the grant opportunity over the preceding Submission Period. 

• Submission Period 1 will contain all applications submitted to the grant opportunity between the opening date and 2:00pm AEST on 14 May 2024.
• Submission Period 2 will contain all applications submitted to the grant opportunity between 2:01pm AEST on 14 May 2024 and 2:00pm AEST on 18 September 2024.
• Submission Period 3 will contain all applications submitted to the grant opportunity between 2:01pm AEST on 18 September 2024 and 2:00pm AEST on 1 August 2025. 

To be eligible you must be one of the following:

• Indigenous Corporation (registered under the Corporations (Aboriginal and /or Torres Strait Islander) Act 2006)
• a registered charity or not-for-profit organisation
• Cancer advocacy groups
• Community Organisations
• Company
• Cooperative
• Incorporated Association
• Statutory Entity, or
• Partnership.

To be eligible, your grant activity must be for a project that will provide improved outcomes for Australian’s living with cancer. Your activity should:

• provide access to high-quality and culturally safe resources and/or care throughout the cancer experience, where applicable;
• be supported by evidence to align with a priority population group and/or increasing equity across tumour types;
• align with the strategic objectives as identified in the Australia Cancer Plan and/or the Aboriginal and Torres Strait Islander Cancer Plan; and
• demonstrate national applicability.